查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702296

2025 年至 2033 年男性不孕症市场报告（按测试类型、治疗、配销通路、最终用户和地区）

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球男性不孕症市场规模价值 42.1 亿美元。展望未来， IMARC Group估计到 2033 年该市场规模将达到 63.2 亿美元，2025-2033 年期间的复合年增长率为 4.51%。欧洲目前占据市场主导地位。男性不孕症盛行率的上升、延迟生育趋势的出现、显着的技术进步、生活方式的改变、对不孕症认识的提高以及辅助生殖技术的合法化是推动市场发展的一些主要因素。

男性不孕症是指男性因生殖系统因素导致女性伴侣无法受孕的情况。这通常归因于精子的产生、品质或输送问题。导致男性不孕的因素包括精子数量低、精子形状或活力异常、荷尔蒙失衡、遗传因素以及某些疾病，如精索静脉曲张（阴囊静脉扩张）。过量饮酒、吸烟、吸毒和肥胖等生活方式因素也会导致男性不孕。

全球男性不孕症发病率的上升是推动市场发展的重要因素。生活方式的改变、环境污染物以及与压力相关的因素加剧了这种担忧，因此需要诊断和治疗方案。此外，为了追求职业目标和其他生活愿望而延迟生育的趋势导致男性与年龄相关的生育问题更加严重。这刺激了对男性不孕症治疗和辅助生殖技术的需求。除此之外，由于教育活动和数位资源的推动，人们对生育问题的认识不断提高，促使更多男性寻求医疗协助来解决不孕症问题，从而推动了市场成长。除此之外，久坐的生活方式、不良的饮食习惯以及接触环境毒素的增加都与精子品质和数量的下降有关。随着人们越来越意识到这些因素，对抵消这些影响的干预和治疗的需求也随之增加。同时，医疗技术的进步提高了男性不孕症诊断程序和治疗方案的准确性。精子DNA碎片分析和先进的精子选择方法等创新技术提高了治疗效果。

男性不孕症市场趋势/驱动因素：

男性不孕症盛行率不断上升

久坐的生活方式、接触环境污染物以及高压力水平等多种因素共同导致了男性生育问题的增加。这些因素会对精子的产生、品质和活力产生不利影响。随着人们对男性不孕症盛行率的认识不断提高，对准确诊断和有效治疗方案的需求也日益增长。夫妻正在寻求医疗专业知识来解决这些问题，从而导致生育服务的咨询和采用增加。

延后生育的趋势日益明显

由于社会规范和职业抱负的不断变化，推迟生育的趋势日益增强。然而，年龄的增长与男性生育能力的下降有关，包括精子品质下降和 DNA 碎片化增加。这种现象导致了男性因年龄增加而出现生育困难。因此，男性不孕症市场见证了希望晚年建立家庭的老年男性对生育能力保存和治疗方案的需求激增。这一趋势强调了采取专门干预措施以满足这一人群的独特需求的必要性。

重大技术进步

精子DNA碎片分析等创新技术可以更全面地评估精子品质。此外，先进的精子选择方法，例如磁激活细胞分选（MACS），提高了成功受精的机会。这些技术提高了识别不孕症根本原因的准确性，并为医疗保健专业人员提供了更广泛的工具来製定治疗计划。随着技术的不断发展，它有可能透过为患者提供更有效和个人化的解决方案来显着改善治疗结果并促进男性不孕症市场的成长。

按测试类型分类：

  • 精子凝集试验
  • DNA片段化技术
  • 氧化压力分析
  • 电脑辅助精液分析
  • 精子穿透试验
  • 其他的

DNA片段化技术占市场主导地位

DNA碎片化技术因其能够对男性不孕症提供更深入的了解，成为按测试类型分類的市场中最大的细分领域。该技术评估精子内的 DNA 损伤，提供有关精子品质的关键资讯。因此，它在准确诊断男性不孕症的根本原因、指导个人化治疗方法以获得更好的结果方面发挥了重要作用。

按治疗分类：

  • 药物
  • 辅助生殖技术与精索静脉曲张手术

辅助生殖技术和精索静脉曲张手术占据最大市场份额

ART 包括体外受精 (IVF) 和卵胞浆内单一精子注射 (ICSI) 等技术，为夫妻提供了克服各种生育挑战的机会，包括男性不孕症。 ART 的成功率和进步使其成为领先的选择。另一方面，精索静脉曲张手术是一种成熟的治疗精索静脉曲张的手术介入方法，精索静脉曲张是阴囊内的静脉扩张，会阻碍精子的产生和品质。透过手术矫正精索静脉曲张，可以改善血液流动，从而有可能增强精子的产生和活力。该手术在恢復生育能力方面已显示出积极的成果。这些治疗方法之所以受欢迎，是因为它们已被证实有效，从而在市场治疗领域中占据突出地位。

依配销通路分类：

  • 医院药房
  • 药局和药局
  • 网路药局

男性不孕症产品主要透过医院药局销售

医院提供一系列专业的诊断设施、医疗专业知识和治疗方案。这使得它们成为寻求全面评估、生育专家咨询以及先进干预措施（包括辅助生殖技术 (ART) 和外科手术）的患者的主要目的地。药局透过提供支持男性生殖健康的处方药、补充剂和生育相关产品发挥至关重要的作用。它们为患者提供了获取生育治疗和管理处方药的便捷途径。此外，药局提供了一个谨慎的环境，个人可以在这里获得非处方生育补充剂和补充治疗计划的产品。

按最终用户分类：

  • 医院和诊所
  • 生育中心
  • 研究机构
  • 其他的

生育中心占据了大部分市场份额

这些中心致力于为面临生育挑战的个人和夫妇提供广泛的客製化服务。生育中心拥有一支经验丰富的生殖内分泌学家、泌尿科医生、胚胎学家和其他专家团队，他们共同提供先进的诊断评估、个人化治疗计划和辅助生殖技术 (ART)。生育中心的多学科性质使得可以对男性不孕症采取整体治疗，包括医学评估、实验室分析和创新治疗。这些中心提供支持性环境，解决生育困难的情绪和身体方面的问题。拥有最先进的技术、尖端的程序以及对男性生殖健康的全面了解，使得生育中心成为寻求专家指导和成功结果以克服男性不孕症的个人的首选。

按地区划分：

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
  • 中东和非洲

欧洲在市场上占据明显主导地位

该报告还对所有主要区域市场进行了全面的分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，欧洲占最大的市场份额。

该地区拥有完善的医疗保健基础设施，包括先进的医疗设施、生育诊所和研究机构，能够有效诊断和治疗男性不孕症。此外，社会文化动态的变化提高了人们对生育问题的认识和接受度，促使更多的个人和夫妻寻求医疗介入。欧洲国家也重视生殖健康，并提供全面的医疗保健，使更多人能够接受生育治疗。随着该地区人口老化，延迟生育变得越来越普遍，对辅助生殖技术（ART）的需求也日益增长。此外，欧洲在医学研发领域的强大影响力推动了男性不孕症治疗的创新，吸引了国内外寻求尖端解决方案的患者。

竞争格局：

领先的公司正在大力投资研发，以创造新的和改进的男性不孕症诊断工具、治疗方法和技术。这包括开发创新的精子分析技术、药物和辅助生殖技术以提高治疗效果。此外，主要参与者经常与学术机构、研究组织和医疗保健提供者合作，交流知识、分享见解并推动男性不孕症诊断和治疗的进步。这些合作促进了应对复杂挑战和开发全面解决方案的协同方法。除此之外，认识到提高男性不孕意识的重要性，行业领导者积极参与教育活动。他们透过线上平台、研讨会和医疗保健专业培训提供信息，旨在提高对病情的了解并鼓励及时干预。此外，主要参与者正在进行策略性扩张，以进入对男性不孕症治疗需求不断增长的新兴市场。透过扩大覆盖范围，他们旨在为更广泛的患者群体提供先进的诊断和治疗方法。

市场研究报告对市场竞争格局进行了全面的分析。也提供了所有主要公司的详细资料。市场中的一些主要参与者包括：

  • 男科解决方案
  • CinnaGen公司
  • Halotech DNA
  • SCSA 诊断公司
  • 维特罗莱夫
  • Zydus生命科学有限公司
  • 英塔斯製药股份有限公司
  • Endo 国际有限公司

最新动态：

男性科学解决方案在男性不孕症领域取得了最新进展，包括对男性因素不孕症的理解和管理的改善。它还致力于开发男性不孕基因面板，在诊断拷贝数变异（CNV）方面​​取得了很高的准确性。这些进步有助于男性不孕症的诊断和治疗，从而实现更有效的干预并改善治疗结果。

Halotech DNA 是一家总部位于马德里的国际领先生物技术公司，推出了用于评估精子品质的创新 DNA 碎片分析系统。这些系统旨在评估精子细胞的 DNA 损伤程度，这可能是导致男性不孕症的因素。此分析有助于确定不孕症的根本原因并指导选择适当的治疗方案。

2022 年，SCSA Diagnostics Inc. 开发了一项名为 SCSA（精子染色质结构分析）的测试，用于评估精子染色质结构和 DNA 链断裂。 SCSA 测试是一种同时进行流式细胞仪测量精子核单股 (ss) 和双股 (ds) DNA 断裂程度的双重方法。该测试透过评估精子 DNA 的完整性提供有关男性不孕症的独特讯息，这对于成功受精和胚胎发育至关重要。

本报告回答的关键问题

  • 男性不孕市场有多大
  • 男性不孕症市场的未来前景如何
  • 推动全球男性不孕症市场的关键因素有哪些
  • 哪个地区占据男性不孕症最大的市场份额
  • 全球男性不孕症市场领先的公司有哪些

本报告回答的关键问题

  • 男性不孕市场有多大？男性不孕症市场的未来前景如何？
  • 推动全球男性不孕症市场发展的关键因素有哪些？
  • 哪个地区占据男性不孕症最大的市占率？
  • 全球男性不孕症市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球男性不孕症市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依测试类型

  • 精子凝集试验
  • DNA片段化技术
  • 氧化压力分析
  • 电脑辅助精液分析
  • 精子穿透试验
  • 其他的

第七章：市场区隔：依处理方式

  • 药物
  • 辅助生殖技术与精索静脉曲张手术

第八章：市场区隔：按配销通路

  • 医院药房
  • 药局和药局
  • 网路药局

第九章：市场区隔：依最终用户

  • 医院和诊所
  • 生育中心
  • 研究机构
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Andrology Solutions
    • CinnaGen Co.
    • Halotech DNA
    • SCSA Diagnostics Inc.
    • Vitrolife
    • Zydus Lifesciences Limited
    • Intas Pharmaceuticals Ltd.
    • Endo International plc
Product Code: SR112025A6416

The global male infertility market size was valued at USD 4.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 6.32 Billion by 2033, exhibiting a CAGR of 4.51% during 2025-2033. Europe currently dominates the market. The rise in the prevalence of male infertility, emerging trend of delayed parenthood, notable technological advancements, changing lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

Male infertility refers to the condition in which a man is unable to impregnate a female partner due to factors related to his reproductive system. It is often attributed to issues with sperm production, quality, or delivery. Factors that can contribute to male infertility include low sperm count, abnormal sperm shape or motility, hormonal imbalances, genetic factors, and certain medical conditions like varicocele (enlarged veins in the scrotum). Lifestyle factors such as excessive alcohol consumption, smoking, drug use, and obesity can also play a role in male infertility.

The rising incidence of male infertility worldwide is a significant driver for the market. Changing lifestyles, environmental pollutants, and stress-related factors contribute to this growing concern, necessitating the need for diagnostic and treatment solutions. Additionally, the trend of delaying parenthood to pursue career goals and other life aspirations has led to higher age-related fertility issues among men. This has spurred the demand for male infertility treatments and assisted reproductive technologies. Other than this, increasing awareness about fertility issues, thanks to educational campaigns and digital resources, has prompted more men to seek medical assistance for infertility problems, thus driving the market growth. Besides this, sedentary lifestyles, poor dietary habits, and increased exposure to environmental toxins have been linked to declining sperm quality and quantity. As individuals become more conscious of these factors, the demand for interventions and treatments to counteract these effects has risen. In line with this, advancements in medical technologies have improved the accuracy of diagnostic procedures and treatment options for male infertility. Innovative techniques such as sperm DNA fragmentation analysis and advanced sperm selection methods have enhanced treatment outcomes.

Male Infertility Market Trends/Drivers:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high stress levels, have collectively contributed to a rise in fertility issues among men. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The trend of delaying parenthood has gained momentum due to evolving societal norms and career aspirations. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a surge in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis enable a more comprehensive assessment of sperm quality. Additionally, advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), enhance the chances of successful fertilization. These technologies offer improved accuracy in identifying underlying causes of infertility and provide healthcare professionals with a wider range of tools to tailor treatment plans. As technology continues to evolve, it has the potential to significantly improve outcomes and contribute to the growth of the male infertility market by providing patients with more effective and personalized solutions.

Breakup by Test Type:

  • Sperm Agglutination
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

DNA fragmentation technique dominates the market

The DNA fragmentation technique stands as the largest segment in the market breakup by test type due to its ability to offer deeper insights into male infertility. This technique assesses DNA damage within sperm, providing crucial information about sperm quality. As a result, it has gained prominence in accurately diagnosing the underlying causes of male infertility, guiding tailored treatment approaches for better outcomes.

Breakup by Treatment:

  • Medication
  • Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery hold the largest market share

ART, encompassing techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), offers couples the opportunity to overcome various fertility challenges, including male factor infertility. The success rates and advancements in ART have positioned it as a leading choice. Varicocele surgery, on the other hand, is a well-established surgical intervention to treat varicoceles, which are dilated veins in the scrotum that can impede sperm production and quality. By surgically correcting varicoceles, blood flow is improved, potentially enhancing sperm production and motility. This procedure has demonstrated positive outcomes in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's treatment landscape.

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

Male infertility products are majorly distributed through hospital pharmacies

Hospitals offer a range of specialized diagnostic facilities, medical expertise, and treatment options under one roof. This makes them a primary destination for patients seeking comprehensive evaluation, consultations with fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. Pharmacies play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, pharmacies offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Breakup by End User:

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Others

Fertility centers account for the majority of the share in the market

These centers are dedicated to providing a wide range of services specifically tailored to individuals and couples facing fertility challenges. Fertility centers house a team of experienced reproductive endocrinologists, urologists, embryologists, and other specialists who collectively offer advanced diagnostic evaluations, personalized treatment plans, and assisted reproductive technologies (ART) under one roof. The multidisciplinary nature of fertility centers allows for a holistic approach to male infertility, encompassing medical assessments, laboratory analyses, and innovative treatments. These centers offer a supportive environment that addresses the emotional and physical aspects of fertility struggles. The availability of state-of-the-art technologies, cutting-edge procedures, and a comprehensive understanding of male reproductive health positions fertility centers as the preferred choice for individuals seeking expert guidance and successful outcomes in their journey towards overcoming male infertility.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Europe exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.

The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. Moreover, changing socio-cultural dynamics have led to increased awareness and acceptance of fertility issues, prompting more individuals and couples to seek medical intervention. European countries also prioritize reproductive health and offer comprehensive healthcare coverage, making fertility treatments more accessible to a larger population. The aging population across the region contributes to a growing demand for assisted reproductive technologies (ART) as delayed parenthood becomes more common. Furthermore, the strong presence of Europe in medical research and development fuels innovations in male infertility treatments, attracting both domestic and international patients seeking cutting-edge solutions.

Competitive Landscape:

Leading companies are investing significantly in research and development to create new and improved diagnostic tools, treatments, and technologies for male infertility. This includes developing innovative sperm analysis techniques, medications, and assisted reproductive technologies to enhance treatment outcomes. Additionally, key players often collaborate with academic institutions, research organizations, and healthcare providers to exchange knowledge, share insights, and drive advancements in male infertility diagnostics and treatments. These collaborations foster a synergistic approach to tackling complex challenges and developing comprehensive solutions. Other than this, recognizing the importance of raising awareness about male infertility, industry leaders are actively involved in educational initiatives. They offer information through online platforms, seminars, and healthcare professional training, aimed at increasing understanding of the condition and encouraging timely interventions. Moreover, key players engage in strategic expansion efforts to tap into emerging markets with growing demand for male infertility treatments. By extending their reach, they aim to provide access to advanced diagnostics and therapies to a wider patient population.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Andrology Solutions
  • CinnaGen Co.
  • Halotech DNA
  • SCSA Diagnostics Inc.
  • Vitrolife
  • Zydus Lifesciences Limited
  • Intas Pharmaceuticals Ltd.
  • Endo International plc.

Recent Developments:

Andrology Solutions has made recent advancements in the field of male infertility, including improvements in the understanding and management of male factor infertility. It has also worked on developing panels for male infertility genes, which have achieved high accuracy in diagnosing copy number variants (CNVs). These advancements contribute to the diagnosis and treatment of male infertility, allowing for more effective interventions and improved outcomes.

Halotech DNA, a leading international biotech company based in Madrid, has introduced innovative DNA fragmentation analysis systems for evaluating sperm quality. These systems are designed to assess the level of DNA damage in sperm cells, which can be a contributing factor to male infertility. This analysis helps in identifying the underlying causes of infertility and guides the selection of appropriate treatment options.

In 2022, SCSA Diagnostics Inc. developed a test called the SCSA (Sperm Chromatin Structure Assay), which is used to evaluate sperm chromatin structure and DNA strand breaks. The SCSA test is a two-fold simultaneous flow cytometry measure of the extent of sperm nuclear single (ss) and double (ds) strand DNA breaks. This test provides unique information about male infertility by assessing the integrity of sperm DNA, which is crucial for successful fertilization and embryo development.

Key Questions Answered in This Report

  • 1.How big is the male infertility market?
  • 2.What is the future outlook of the male infertility market?
  • 3.What are the key factors driving the global male infertility market?
  • 4.Which region accounts for the largest male infertility market share?
  • 5.Which are the leading companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Male Infertility Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Sperm Agglutination
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DNA Fragmentation Technique
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidative Stress Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Computer Assisted Semen Analysis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Sperm Penetration Assay
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Medication
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Assisted Reproductive Technology and Varicocele Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fertility Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Andrology Solutions
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CinnaGen Co.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Halotech DNA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 SCSA Diagnostics Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Vitrolife
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Zydus Lifesciences Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Intas Pharmaceuticals Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Endo International plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Male Infertility Market: Major Drivers and Challenges
  • Figure 2: Global: Male Infertility Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Male Infertility Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Male Infertility Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: Male Infertility Market: Breakup by Treatment (in %), 2024
  • Figure 6: Global: Male Infertility Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Male Infertility Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Male Infertility Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Male Infertility (Sperm Agglutination) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Male Infertility (Sperm Agglutination) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Male Infertility (DNA Fragmentation Technique) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Male Infertility (DNA Fragmentation Technique) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Male Infertility (Oxidative Stress Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Male Infertility (Oxidative Stress Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Male Infertility (Computer Assisted Semen Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Male Infertility (Computer Assisted Semen Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Male Infertility (Sperm Penetration Assay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Male Infertility (Sperm Penetration Assay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Male Infertility (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Male Infertility (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Male Infertility (Medication) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Male Infertility (Medication) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Male Infertility (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Male Infertility (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Male Infertility (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Male Infertility (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Male Infertility (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Male Infertility (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Male Infertility (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Male Infertility (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Male Infertility (Fertility Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Male Infertility (Fertility Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Male Infertility (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Male Infertility (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Male Infertility (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Male Infertility (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Male Infertility Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Male Infertility Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Male Infertility Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Male Infertility Industry: SWOT Analysis
  • Figure 89: Global: Male Infertility Industry: Value Chain Analysis
  • Figure 90: Global: Male Infertility Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Male Infertility Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Male Infertility Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: Male Infertility Market Forecast: Breakup by Treatment (in Million USD), 2025-2033
  • Table 4: Global: Male Infertility Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Male Infertility Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Male Infertility Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Male Infertility Market: Competitive Structure
  • Table 8: Global: Male Infertility Market: Key Players